Valuation: Boule Diagnostics AB

Market Cap 99.02M 10.09M 8.78M 8.31M 7.55M 14.11M 966M 14.18M 38.29M 491M 37.89M 37.04M 1.57B P/E 2026 *
-10.1x
P/E 2027 * 11.5x
Enterprise Value 296M 30.1M 26.22M 24.81M 22.55M 42.12M 2.88B 42.33M 114M 1.47B 113M 111M 4.69B EV / Sales 2026 *
0.65x
EV / Sales 2027 * 0.59x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-2.67%
1 week-8.93%
Current month-18.53%
1 month-25.00%
3 months-22.73%
6 months-35.77%
Current year-48.07%
1 week 2.55
Extreme 2.55
2.76
1 month 2.55
Extreme 2.55
3.41
Current year 2.55
Extreme 2.55
5.68
1 year 2.55
Extreme 2.55
6.64
3 years 2.55
Extreme 2.55
12.62
5 years 2.55
Extreme 2.55
59.5
10 years 2.55
Extreme 2.55
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/23 A Buy

Chief Financial Officer

8,000 0.0206%
2/6/23 A Buy

Director

7,083 0.0182%
2/17/22 A Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-8.93%-56.03%-73.16% 10.41M
+1.53%+9.14%+39.29%+27.70% 240B
+1.99%+5.97%+10.14%-16.75% 146B
+0.33%+6.40%-11.56%+29.78% 135B
-0.82%+1.04%-55.79%-17.67% 63.64B
-1.15%+1.71%+17.35%+20.56% 51.46B
+0.16%0.00%-18.71%-16.71% 49.27B
+1.72%+9.24%+23.37%+34.88% 43.33B
+2.65%+6.99%+41.50%+55.81% 41.13B
+7.10%+21.82%+143.07%+67.76% 34.57B
Average +1.04%+3.97%+13.26%+11.22% 80.47B
Weighted average by Cap. +1.20%+6.57%+16.69%+16.74%

Financials

2026 *2027 *
Net sales 453M 46.15M 40.2M 38.04M 34.56M 64.57M 4.42B 64.89M 175M 2.25B 173M 170M 7.19B 483M 49.23M 42.88M 40.58M 36.87M 68.88M 4.71B 69.22M 187M 2.4B 185M 181M 7.67B
Net income -9.77M -995K -867K -821K -746K -1.39M -95.33M -1.4M -3.78M -48.45M -3.74M -3.66M -155M 8.6M 876K 763K 722K 656K 1.23M 83.85M 1.23M 3.32M 42.61M 3.29M 3.22M 136M
Net Debt 197M 20.02M 17.44M 16.5M 14.99M 28.01M 1.92B 28.15M 76M 974M 75.2M 73.52M 3.12B 185M 18.79M 16.37M 15.49M 14.08M 26.29M 1.8B 26.42M 71.35M 915M 70.6M 69.02M 2.93B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
17/09/26 SEK 2.550 -2.67% 65,573
16/09/26 SEK 2.620 +1.55% 61,979
15/09/26 SEK 2.580 -1.15% 50,576
14/09/26 SEK 2.610 -3.69% 28,001
11/09/26 SEK 2.710 -3.21% 75,476
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.550SEK
Average target price
3.800SEK
Spread / Average Target
+49.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!